yervoy

Generic: ipilimumab

Labeler: e.r. squibb & sons, l.l.c.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name yervoy
Generic Name ipilimumab
Labeler e.r. squibb & sons, l.l.c.
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

ipilimumab 5 mg/mL

Manufacturer
E.R. Squibb & Sons, L.L.C.

Identifiers & Regulatory

Product NDC 0003-2327
Product ID 0003-2327_ecc3bf01-2632-4c2e-85aa-e34da43d25f2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125377
Listing Expiration 2026-12-31
Marketing Start 2011-03-25

Pharmacologic Class

Established (EPC)
ctla-4-directed blocking antibody [epc]
Mechanism of Action
ctla-4-directed antibody interactions [moa]
Physiologic Effect
increased t lymphocyte activation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00032327
Hyphenated Format 0003-2327

Supplemental Identifiers

RxCUI
1657005 1657007 1657012 1657013
UNII
6T8C155666
NUI
N0000182635 N0000182634 N0000182157

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name yervoy (source: ndc)
Generic Name ipilimumab (source: ndc)
Application Number BLA125377 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 5 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (0003-2327-11) / 10 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (1)

0003-2327-11 1 VIAL, SINGLE-USE in 1 CARTON (0003-2327-11) / 10 mL in 1 VIAL, SINGLE-USE

Ingredients (1)

ipilimumab (5 mg/mL)

Linked Drug Pages (1)

YERVOY ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "ecc3bf01-2632-4c2e-85aa-e34da43d25f2", "openfda": {"nui": ["N0000182635", "N0000182634", "N0000182157"], "unii": ["6T8C155666"], "rxcui": ["1657005", "1657007", "1657012", "1657013"], "spl_set_id": ["2265ef30-253e-11df-8a39-0800200c9a66"], "pharm_class_pe": ["Increased T Lymphocyte Activation [PE]"], "pharm_class_epc": ["CTLA-4-directed Blocking Antibody [EPC]"], "pharm_class_moa": ["CTLA-4-directed Antibody Interactions [MoA]"], "manufacturer_name": ["E.R. Squibb & Sons, L.L.C."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0003-2327-11)  / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "0003-2327-11", "marketing_start_date": "20110325"}], "brand_name": "YERVOY", "product_id": "0003-2327_ecc3bf01-2632-4c2e-85aa-e34da43d25f2", "dosage_form": "INJECTION", "pharm_class": ["CTLA-4-directed Antibody Interactions [MoA]", "CTLA-4-directed Blocking Antibody [EPC]", "Increased T Lymphocyte Activation [PE]"], "product_ndc": "0003-2327", "generic_name": "ipilimumab", "labeler_name": "E.R. Squibb & Sons, L.L.C.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "YERVOY", "active_ingredients": [{"name": "IPILIMUMAB", "strength": "5 mg/mL"}], "application_number": "BLA125377", "marketing_category": "BLA", "marketing_start_date": "20110325", "listing_expiration_date": "20261231"}